Advertisement

Cytokine Responses in Patients with Pneumonia

  • Peter Kragsbjerg
  • Hans Holmberg
Chapter
  • 116 Downloads
Part of the Infectious Disease book series (ID)

Abstract

The importance of proinflammatory cytokines was first appreciated in studies of patients with sepsis or septic shock, but during the 1990s, the research expanded to include a wide range of infectious and other inflammatory conditions. The first investigations of the role of cytokines in lower-respiratory-tract infections were published in 1992. Since then, clinical studies have been performed on different aspects of inflammation in pneumonia. One group of studies focuses on the pathogenesis of bacterial pneumonia. A second group studies the relation between the microbial etiology of pneumonia and the ensuing inflammatory response. A third group relates the cytokine response in bacterial pneumonia to severity [i.e., SIRS (1), APACHE II (2), or other clinical scoring systems]. A fourth group of studies investigates the role of age in relation to the inflammatory response caused by an acute bacterial pneumonia. Finally, in a few studies, the impact of immunomodulating therapy has been investigated.

Keywords

Systemic Inflammatory Response Syndrome Cytokine Response Adult Respiratory Distress Syndrome Bacterial Pneumonia Chlamydia Pneumonia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Rangel-Frausto, M.S., Pittet, D., Costigan, M., Hwang, T., Davis, CS., and Wenzel, R.P. (1995) The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273, 117–123.PubMedCrossRefGoogle Scholar
  2. 2.
    Knaus, W.A., Draper, E.A., Wagner, D.P., and Zimmerman, J.E. (1985) APACHE II: a severity of disease classification system. Crit. Care Med. 13, 818–829.PubMedCrossRefGoogle Scholar
  3. 3.
    Rodriguez, J.L., Miller, C.G., DeForge, L.E., Kelty, L., Shanley, C.J., Bartlett, R.H., et al. (1992) Local production of interleukin-8 is associated with nosocomial pneumonia. J. Trauma 33, 74–81.PubMedCrossRefGoogle Scholar
  4. 4.
    Chollet-Martin, S., Montravers, P., Gibert, C., Elbim, C, Desmonts, J.M., Fagon, J.Y., et al. (1993). High levels of interleukin-8 in the blood and alveolar spaces of patients with pneumonia and adult respiratory distress syndrome. Infect Immun. 61, 4553–4559.PubMedGoogle Scholar
  5. 5.
    Moussa, K., Michie, H.J., Cree, I.A., McCafferty, A.C., Winter, J.H., Dhillon, D.P., et al. (1994) Phagocyte function and cytokine production in community acquired pneumonia. Thorax 49, 107–111.PubMedCrossRefGoogle Scholar
  6. 6.
    Dehoux, M.S., Boutten, A., Ostinelli, J., Seta, N., Dombret, M.C., Crestani, B., et al. (1994). Compartmentalized cytokine production within the human lung in unilateral pneumonia. Am. J. Respir. Crit. Care Med. 150, 710–716.PubMedGoogle Scholar
  7. 7.
    Boutten, A., Dehoux, M.S., Seta, N., Ostinelli, J., Venembre, P., Crestani, B., et al. (1996) Compartmentalized IL-8 and elastase release within the human lung in unilateral pneumonia. Am. J. Respir. Crit. Care Med. 153, 336–342.PubMedGoogle Scholar
  8. 8.
    Villard, J., Dayer-Pastore, F., Hamacher, J., Aubert, J. D., Schlegel-Haueter, S., et al. (1995). GRO alpha and interleukin-8 in Pneumocystis carinii or bacterial pneumonia and adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 152, 1549–1554.PubMedGoogle Scholar
  9. 9.
    Schutte, H., Lohmeyer, J., Rosseau, S., Ziegler, S., Siebert, C, Kielisch, H., et al. (1996). Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema. Eur. Respir. J. 9,1858–1867.PubMedCrossRefGoogle Scholar
  10. 10.
    Bohnet, S., Kotschau, U., Braun, J., and Dalhoff, K. (1997). Role of interleukin-8 in community-acquired pneumonia: relation to microbial load and pulmonary function. Infection 25, 95–100.PubMedCrossRefGoogle Scholar
  11. 11.
    Maus, U., Rosseau, S., Knies, U., Seeger, W., and Lohmeyer, J. (1998) Expression of pro-inflammatory cytokines by flow-sorted alveolar macrophages in severe pneumonia. Eur. Respir. J. 11, 534–541.PubMedGoogle Scholar
  12. 12.
    Buhling, F., Tholert, G., Kaiser, D., Hoffmann, B., Reinhold, D., Ansorge, S., et al. (1999) Increased release of transforming growth factor (TGF)-betal, TGF-beta2, and chemoattractant mediators in pneumonia. J. Interferon Cytokine Res. 19,271–278.PubMedCrossRefGoogle Scholar
  13. 13.
    Montón, C, Torres, A., El-Ebiary, M., Filella, X., Xaubet, A., and de la Bellacasa, J.P. (1999) Cytokine expression in severe pneumonia: a bronchoalveolar lavage study. Crit. Care Med. 27, 1745–1753.PubMedCrossRefGoogle Scholar
  14. 14.
    Kragsbjerg, P., Vikerfors, T., and Holmberg, H. (1993) Serum levels of interleukin-6, tumour necrosis factor-α, interferon-γ and C-reactive protein in adults with community-acquired pneumonia. Serodiagn. Immunother. Infect. Dis. 5, 156–160.CrossRefGoogle Scholar
  15. 15.
    Örtqvist, A., Hedlund, J., Wretlind, B., Carlstrom, A., and Kalin, M. (1995) Diagnostic and prognostic value of interleukin-6 and C-reactive protein in community-acquired pneumonia. Scand. J. Infect. Dis. 27, 457–462.PubMedCrossRefGoogle Scholar
  16. 16.
    Lieberman, D., Livnat, S., Schlaeffer, F., Porath, A., Horowitz, S., and Levy, R. (1997) IL-lbeta and IL-6 in community-acquired pneumonia: bacteremic pneumococcal pneumonia versus Mycoplasma pneumoniae pneumonia. Infection 25, 90–94.PubMedCrossRefGoogle Scholar
  17. 17.
    Kragsbjerg, P., Jones, I., Vikerfors, T., and Holmberg, H. (1995) Diagnostic value of blood cytokine concentrations in acute pneumonia. Thorax 50, 1253–1257.PubMedCrossRefGoogle Scholar
  18. 18.
    Kragsbjerg, P., Holmberg, H., and Vikerfors, T. (1996) Dynamics of blood cytokine concentrations in patients with bacteremic infections. Scand. J. Infect. Dis. 28, 391–398.PubMedCrossRefGoogle Scholar
  19. 19.
    Bruunsgaard, H., Skinhoj, P., Qvist, J., and Pedersen, B.K. (1999) Elderly humans show prolonged in vivo inflammatory activity during pneumococcal infections. J. Infect. Dis. 180, 551–554.PubMedCrossRefGoogle Scholar
  20. 20.
    Kragsbjerg, P., Vikerfors, T., and Holmberg, H. (1998) Cytokine responses in patients with pneumonia caused by Chlamydia or Mycoplasma. Respiration 65, 299–303.CrossRefGoogle Scholar
  21. 21.
    Pauksen, K., Elfman, L., Ulfgren, A.K., and Venge, P. (1994) Serum levels of granulocyte-colony stimulating factor (G-CSF) in bacterial and viral infections, and in atypical pneumonia. Br. J. Haematol. 88, 256–260.PubMedCrossRefGoogle Scholar
  22. 22.
    Tateda, K., Matsumoto, T., Ishii, Y., Furuya, N., Ohno, A., Miyazaki, S., et al. (1998) Serum cytokines in patients with Legionella pneumonia: relative predominance of Thl-type cytokines. Clin. Diagn. Lab. Immunol. 5, 401–403.PubMedGoogle Scholar
  23. 23.
    Puren, A.J., Feldman, C, Savage, N., Becker, P.J., and Smith, C. (1995) Patterns of cytokine expression in community-acquired pneumonia. Chest 107, 1342–1349.PubMedCrossRefGoogle Scholar
  24. 24.
    de Werra, I., Jaccard, C, Corradin, S.B., Chiolero, R., Yersin, B., Gallati, H., et al. (1997) Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit. Care Med. 25, 607–613.PubMedCrossRefGoogle Scholar
  25. 25.
    Glynn, P., Coakley, R., Kilgallen, I., Murphy, N., and O’Neill, S. (1999) Circulating interleukin 6 and interleukin 10 in community acquired pneumonia. Thorax 54, 51–55.PubMedCrossRefGoogle Scholar
  26. 26.
    Bauer, T.T., Montón, C, Torres, A., Cabello, H., Filíela, X., Maldonado, A., et al. (2000) Comparison of systemic cytokine levels in patients with acute respiratory distress syndrome, severe pneumonia, and controls. Thorax 55,46–52.PubMedCrossRefGoogle Scholar
  27. 27.
    Gon, Y., Hashimoto, S., Hayashi, S., Koura, T., Matsumoto, K., and Horie, T. (1996) Lower serum concentrations of cytokines in elderly patients with pneumonia and the impaired production of cytokines by peripheral blood monocytes in the elderly. Clin. Exp. Immunol. 106, 120–126.PubMedGoogle Scholar
  28. 28.
    Marik, P., Kraus, P., Sribante, J., Havlik, I., Lipman, J., and Johnson, D.W. (1993) Hydrocortisone and tumor necrosis factor in severe community-acquired pneumonia. A randomized controlled study. Chest 104, 389–392.PubMedCrossRefGoogle Scholar
  29. 29.
    Montón, C, Ewig, S., Torres, A., El-Ebiary, M., Filella, X., Rano, A., et al. (1999). Role of glucocorticoids on inflammatory response in nonimmunosuppressed patients with pneumonia: a pilot study. Eur. Respir. J. 14, 218–220.PubMedCrossRefGoogle Scholar
  30. 30.
    Nelson, S., Belknap, S.M., Carlson, R.W., Dale, D., DeBoisblanc, B., Farkas, S., et al. (1998) A randomized controlled trial of filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community- acquired pneumonia. CAP Study Group. J. Infect. Dis. 178, 1075–1080.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Peter Kragsbjerg
  • Hans Holmberg

There are no affiliations available

Personalised recommendations